Catherine Bornbaum, PhD, MBA, Chief Business Officer at RetiSpec, says retinal biomarkers and artificial intelligence can reshape diagnosis and care...
In the past decade, artificial intelligence (AI) has slowly seeped into medicine, promising to revolutionize diagnostics, treatment planning, and patient...